The unhysterical Lancet Haematology wrote a recent editorial on “the big business of blood plasma.” The financial incentive, it read, “can encourage lying during medical screening and could adversely affect the health of some of the donors as well. With some companies pooling hundreds of thousands of donations together for processing, this can be an important safety risk.”
